Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study
- 31 March 2008
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 197 (1), 443-447
- https://doi.org/10.1016/j.atherosclerosis.2007.06.033
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Th1/Th2 Imbalance, Measured by Circulating and Intracytoplasmic Inflammatory Cytokines – Immunological Alterations in Acute Coronary Syndrome and Stable Coronary Artery DiseaseScandinavian Journal of Immunology, 2006
- Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomyEuropean Heart Journal, 2006
- Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: Further evidence for the inflammatory basis of atherosclerosisAmerican Heart Journal, 2005
- Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectorisThe American Journal of Cardiology, 2003
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisThe New England Journal of Medicine, 2000
- Expression of Interleukin-10 in Advanced Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.The Journal of Experimental Medicine, 1996
- Immunosuppressive and Anti-inflammatory Properties of Interleukin 10Annals of Medicine, 1995
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991